NCT04950803View on ClinicalTrials.gov

A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Recovered COVID-19 Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

448

Participants

Timeline

Start Date

June 25, 2021

Primary Completion Date

May 31, 2027

Study Completion Date

December 31, 2027

Conditions
COVID-19Probiotic
Interventions
DIETARY_SUPPLEMENT

Microbiome immunity formula

Microbiome immunity formula contains probiotics blend (3Bifidobacteria, 20 billion CFU daily)

DIETARY_SUPPLEMENT

Active placebo

Active placebo contains active vitamin

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER